Abstract:
A composition comprising 8-(tosylamino)quinoline is provided to inhibit production of nitric oxide, growth of cancer cells and C6 glioma cell, production of PGE2(prostaglandin 2), and activity of IKK(I kappa B alpha kinase) and Src kinase, thereby preventing or treating inflammatory diseases, immune diseases or tumors. The composition for preventing or treating inflammatory diseases, immune diseases or tumors comprises 8-(tosylamino)quinoline or pharmaceutically acceptable salts thereof including an acid addition salt selected from hydrochloric acid, hydrobromic acid, phosphonic acid, sulfuric acid, tartaric acid, acetic acid, citric acid, malic acid, methanesulphonic acid and gluconic acid.
Abstract:
A composition of solvent extract from Berberis koreana Palibin is provided to suppress the generation of nitric oxide, TNF-alpha and prostaglandin E2(PGE2) and regulates the function of macrophage. A method for manufacturing a butanol fraction of Berberis koreana Palibin comprises: a step of extracting the Berberis koreana Palibin in the water of 20-100°C to obtain concentrate; a step of suspending the concentrate with water and a step of fraction-extracting the suspension with hexane, ethylacetate and butanol. A pharmaceutical composition for treating inflammatory disease or immune-modulating comprises the butanol fraction of water extract of Berberis koreana Palibin. The inflammatory disease is arthritis, the sepsis, and inflammation or the autoimmune disease.